ResMed (RMD) Reports In-Line Q3 EPS, Miss on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.44 -0.67%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.71, in-line with the analyst estimate of $0.71. Revenue for the quarter came in at $514.2 million versus the consensus estimate of $519.87 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
